logo
Science Portal
Copyright © Médecins Sans Frontières
v2.1.5145.produseast1
About MSF Science Portal
About
Contact Us
Frequently Asked Questions (FAQs)
Privacy Policy
Terms of Use
Copyright © Médecins Sans Frontières
v2.1.5145.produseast1
Decline in national tuberculosis notifications with national scale-up of antiretroviral therapy in Malawi | Journal Article / Research | MSF Science Portal
Journal Article
|Research

Decline in national tuberculosis notifications with national scale-up of antiretroviral therapy in Malawi

Kanyerere H, Mganga A, Harries AD, Tayler-Smith K, Jahn A, Chimbwandira F, Mpunga J
Download

Similar Content
Loading...
Loading...
Loading...
Abstract
From 2000 to 2012, Malawi scaled up antiretroviral therapy (ART) from <3000 to 404 905 persons living with HIV/AIDS (human immunodeficiency virus/acquired immune-deficiency syndrome), representing an ART coverage of 40.6% among those living with HIV. During this time, annual tuberculosis (TB) notifications declined by 28%, from 28 234 to 20 463. Percentage declines in annual TB case notifications were as follows: new TB (26%), recurrent TB (40%), new smear-positive pulmonary TB (19%), new smear-negative pulmonary TB (42%), extra-pulmonary TB (19%), HIV-positive TB (30%) and HIV-negative TB (10%). The decline in TB notifications is associated with ART scale-up, supporting its value in controlling TB in high HIV prevalence areas in sub-Saharan Africa.

Countries

Malawi

Subject Area

tuberculosisHIV/AIDS

Languages

English
DOI
10.5588/pha.14.0018
Published Date
21 Jun 2014
PubMed ID
26399210
Journal
Public Health Action
Volume | Issue | Pages
Volume 4, Issue 2, Pages 113-115
Issue Date
2013-09-21
Dimensions Badge